Basal Ganglia Diseases
Recent clinical, regulatory, research and industry developments relating to this disease.
The Genetics of Primary Familial Brain Calcification: A Literature Review.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes2
- Basal Ganglia Diseases1
- Brain Diseases1
Leading journals1
- International journal of molecular sciences1
Leading researchers6
- Chen SY1
- Ho CJ1
- Lan MY1
- Lin CH1
- Lu YT1
- Tsai MH1
Affiliations (unnormalised)5
- Center for Mitochondrial Research and Medicine1
- Center for Parkinson's Disease1
- Genomics and Proteomics Core Laboratory1
- Kaohsiung Chang Gung Memorial Hospital1
- School of Medicine1
Reference
Authoritative identity, definition & identifiers.
Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.